Literature DB >> 19306814

Surgical management of gallbladder cancer.

Srinevas K Reddy1, Bryan M Clary.   

Abstract

This article describes the epidemiology, risk factors, diagnostic imaging tools, and operative management of gallbladder cancer. The rarity of gallbladder cancer coupled with the prevalence of benign gallbladder disease mean that most patients undergo initial procedures that violate tumor planes, complicating attempts at future oncologic resection. Fortunately, a previous laparoscopic or open cholecystectomy does not lessen survival after definitive surgical extirpation. Large retrospective and underpowered prospective studies have suggested benefit to adjuvant chemotherapy or radiotherapy; however, these results need to be confirmed with large prospective randomized trials.

Entities:  

Mesh:

Year:  2009        PMID: 19306814     DOI: 10.1016/j.soc.2008.12.004

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  13 in total

1.  Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.

Authors:  Samuel J Wang; Andrew Lemieux; Jayashree Kalpathy-Cramer; Celine B Ord; Gary V Walker; C David Fuller; Jong-Sung Kim; Charles R Thomas
Journal:  J Clin Oncol       Date:  2011-11-07       Impact factor: 44.544

2.  Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer.

Authors:  Durgatosh Pandey; Pankaj Kumar Garg; N M L Manjunath; Jyoti Sharma
Journal:  J Gastrointest Cancer       Date:  2015-09

3.  Diagnosis of incidental gallbladder cancer after laparoscopic cholecystectomy: our experience.

Authors:  Alessia G Ferrarese; Mario Solej; Stefano Enrico; Alessandro Falcone; Silvia Catalano; Giada Pozzi; Silvia Marola; Valter Martino
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

4.  A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro.

Authors:  Wei Sun; Yue Z Fan; Wen Z Zhang; Chun Y Ge
Journal:  J Exp Clin Cancer Res       Date:  2011-04-29

5.  Effect of marital status on the survival of patients with gallbladder cancer treated with surgical resection: a population-based study.

Authors:  Dou-Sheng Bai; Ping Chen; Jian-Jun Qian; Sheng-Jie Jin; Guo-Qing Jiang
Journal:  Oncotarget       Date:  2017-04-18

6.  Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.

Authors:  Jing-Tao Zhang; Wei Sun; Wen-Zhong Zhang; Chun-Yan Ge; Zhong-Yan Liu; Ze-Ming Zhao; Xing-Sui Lu; Yue-Zu Fan
Journal:  BMC Cancer       Date:  2014-03-15       Impact factor: 4.430

7.  Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.

Authors:  Hui Wang; Wei Sun; Wen-Zhong Zhang; Chun-Yan Ge; Jing-Tao Zhang; Zhong-Yan Liu; Yue-Zu Fan
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

8.  Expression of cluster of differentiation 74 in gallbladder carcinoma and the correlation with epithelial growth factor receptor levels.

Authors:  Peng Wang; Qiao Shi; Teng Zuo; Xiaobo He; Jia Yu; Weixing Wang
Journal:  Oncol Lett       Date:  2016-02-08       Impact factor: 2.967

9.  Evaluation of P53, E-cadherin, Cox-2, and EGFR protein immunoexpression on prognostic of resected gallbladder carcinoma.

Authors:  Sergio Renato Pais-Costa; José Francisco de Matos Farah; Ricardo Artigiani-Neto; Sandro José Martins; Alberto Goldenberg
Journal:  Arq Bras Cir Dig       Date:  2014 Apr-Jun

10.  Up-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer.

Authors:  Wei Lu; Yang Cao; Yijian Zhang; Sheng Li; Jian Gao; Xu-An Wang; Jiasheng Mu; Yun-Ping Hu; Lin Jiang; Ping Dong; Wei Gong; Yingbin Liu
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.